https://investorshangout.com/images/MYImages/53933
Post# of 263


What I Discovered in 2020 (Condensed for Public Drop)
In 2020, I wasn’t just watching a trial I was watching a war unfold:
1. The FDA wasn’t acting in good faith delays and excuses masked deeper sabotage.
2. Some inside tried to help. Others blocked the door. I saw both.
3. Leronlimab wasn’t just a drug it was a threat to something bigger.
4. The company didn’t realize how far the interference went. I did.
5. Public health decisions were already being steered not by safety, but by influence.
6. I was being watched
not for what I wrote, but for what I understood.
There was more going on.
Another company. Another agenda.
I set bait back in 2020 and others helped behind the scenes. I see everything you never wanted to get out.
All other emails redacted too many good FDA employees trying to help. A few bad ones make the entire FDA look bad.
DOJ you are next

EUA was always going to be denied. I knew that before they even tried to cover it up. Thanks insiders.


Vg Total Stock Market ETF (VTI) Stock Research Links
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
Headquarters: Washington, DC
Mailing & correspondence: 1930 18th St NW Suite B2 PMB 2161, Washington DC 20009
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36